We are live on ! Find out more
AACR

ACR Alpine Capital Research Portfolio holdings

AUM $7.04B
1-Year Est. Return 28%
This Fund
S&P 500
This Quarter Est. Return
+4.92%
1 Year Est. Return
+28%
3 Year Est. Return
+58.09%
5 Year Est. Return
+55.24%
10 Year Est. Return
+208.51%
AUM
$600M
AUM Growth
+$105M
Cap. Flow
+$80.8M
Cap. Flow %
13.45%
Top 10 Hldgs %
87.89%
Holding
27
New
7
Increased
15
Reduced
Closed

Top Buys

Rank Stock Value
1
RFP
Resolute Forest Products Inc.
RFP
+$15.2M
2
WMT icon
Walmart Inc
WMT
+$13.6M
3
JNJ icon
Johnson & Johnson
JNJ
+$11.4M
4
VOD icon
Vodafone
VOD
+$6.59M
5
SYY icon
Sysco
SYY
+$6.15M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 30.22%
2 Technology 19.69%
3 Consumer Staples 15.88%
4 Financials 15.52%
5 Industrials 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KINS icon
26
Kingstone Companies
KINS
$285M
$174K 0.03%
25,000

Similar funds

ACR Alpine Capital Research's Q1 2014 Portfolio in Review

As of Q1 2014, ACR Alpine Capital Research held 27 positions worth $600M, up 21% from $496M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

ACR Alpine Capital Research deployed $80.8M of net new capital in Q1 2014, opening 7 new positions and adding to 15 existing holdings. Its largest new stake was MetLife: 7,293 shares worth $343K.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Staples.

  • ACR Alpine Capital Research's largest Q1 2014 buy was MetLife: 7,293 shares worth $343K.
  • ACR Alpine Capital Research added most to Resolute Forest Products Inc. in Q1 2014, an estimated $15.2M increase.
  • ACR Alpine Capital Research's ten largest holdings make up 88% of its $600M portfolio in Q1 2014.
  • ACR Alpine Capital Research opened 7 new positions and closed 0 in Q1 2014.
  • ACR Alpine Capital Research's portfolio value rose 21% quarter-over-quarter to $600M.

Based on ACR Alpine Capital Research's 13F filing for Q1 2014, filed 12 May 2014.